AO Research Institute Davos, Davos Platz 7270, Switzerland; Department of Biomedical Engineering, University of Basel, Allschwil 4123, Switzerland.
AO Research Institute Davos, Davos Platz 7270, Switzerland.
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111701. doi: 10.1016/j.msec.2020.111701. Epub 2020 Nov 5.
Injury of articular cartilage leads to an imbalance in tissue homeostasis, and due to the poor self-healing capacity of cartilage the affected tissue often exhibits osteoarthritic changes. In recent years, injectable and highly tunable composite hydrogels for cartilage tissue engineering and drug delivery have been introduced as a desirable alternative to invasive treatments. In this study, we aimed to formulate injectable hydrogels for drug delivery and cartilage tissue engineering by combining different concentrations of hyaluronic acid-tyramine (HA-Tyr) with regenerated silk-fibroin (SF) solutions. Upon enzymatic crosslinking, the gelation and mechanical properties were characterized over time. To evaluate the effect of the hydrogel compositions and properties on extracellular matrix (ECM) deposition, bovine chondrocytes were embedded in enzymatically crosslinked HA-Tyr/SF composites (in further work abbreviated as HA/SF) or HA-Tyr hydrogels. We demonstrated that all hydrogel formulations were cytocompatible and could promote the expression of cartilage matrix proteins allowing chondrocytes to produce ECM, while the most prominent chondrogenic effects were observed in hydrogels with HA20/SF80 polymeric ratios. Unconfined mechanical testing showed that the compressive modulus for HA20/SF80 chondrocyte-laden constructs was increased almost 10-fold over 28 days of culture in chondrogenic medium which confirmed the superior production of ECM in this hydrogel compared to other hydrogels in this study. Furthermore, in hydrogels loaded with anabolic and anti-inflammatory drugs, HA20/SF80 hydrogel showed the longest and the most sustained release profile over time which is desirable for the long treatment duration typically necessary for osteoarthritic joints. In conclusion, HA20/SF80 hydrogel was successfully established as a suitable injectable biomaterial for cartilage tissue engineering and drug delivery applications.
关节软骨损伤导致组织平衡失衡,由于软骨自我修复能力差,受影响的组织通常表现出骨关节炎的变化。近年来,可注射的、高度可调的用于软骨组织工程和药物输送的复合水凝胶作为一种有吸引力的替代侵入性治疗方法被引入。在这项研究中,我们旨在通过将不同浓度的透明质酸-酪胺(HA-Tyr)与再生丝素(SF)溶液结合,来制备用于药物输送和软骨组织工程的可注射水凝胶。通过酶交联,随着时间的推移对凝胶化和机械性能进行了表征。为了评估水凝胶组成和性能对细胞外基质(ECM)沉积的影响,将牛软骨细胞包埋在酶交联的 HA-Tyr/SF 复合材料(在进一步的工作中简称为 HA/SF)或 HA-Tyr 水凝胶中。我们证明,所有水凝胶配方均具有细胞相容性,并能促进软骨基质蛋白的表达,使软骨细胞产生 ECM,而在具有 HA20/SF80 聚合物比的水凝胶中观察到最显著的软骨生成作用。无约束力学测试表明,在软骨形成培养基中培养 28 天后,HA20/SF80 负载软骨细胞的构建体的压缩模量增加了近 10 倍,这证实了与本研究中的其他水凝胶相比,该水凝胶中 ECM 的产生更优越。此外,在负载合成代谢和抗炎药物的水凝胶中,HA20/SF80 水凝胶随着时间的推移表现出最长和最持续的释放曲线,这对于通常需要用于骨关节炎关节的长治疗持续时间是理想的。总之,HA20/SF80 水凝胶成功地被确立为一种适用于软骨组织工程和药物输送应用的可注射生物材料。